Filter Results


Study status

(for at least one location)



Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-29 of 29 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  2. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types

    Rochester, MN

  3. Early pancreatic cancer detection

    Jacksonville, FL

  4. Immune Response to Antigens

    Jacksonville, FL

  5. A Study of DNA Markers for the Detection of Metastatic Melanoma in Blood

    Rochester, MN

  6. Melanoma In-transit Tissue Bank and Molecular Analysis for Personalized Therapies

    Rochester, MN

  7. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

  8. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL


Mayo Clinic Footer